To investigate whether miR-216b-5p regulated the progression of HCC cells by targeting DLX2, the cell function recovery experiments were detected by MTT, Annexin V-FITC/PI and transwell assays. The gene discussed is ANXA5; the disease is hepatocellular carcinoma.